---
$id: https://graph.org.ai/products/commodity/51281811
$type: Product
source: UNSPSC
code: "51281811"
title: "Detorubicin"
class: "51281800"
classTitle: "Anthracyclines"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Detorubicin

**UNSPSC Code**: 51281811
**Class**: [Anthracyclines](Anthracyclines.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anthracycline antibiotic with the molecular formula C33H39NO14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 822EC3XEJZ, chemically known as glyoxylic acid 3(sup 2)-ester with doxorubicin, 2-(diethyl acetal) but generally known as detorubicin, which bears US NIH Compound Identifier 114806. European Medicines Agency schedules Detorubicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07013MIG. The term DETORUBICIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). DETORUBICIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule detorubicin under HS 29419000 and SITC 54139. As of Q4 2014, DETORUBICIN remains the US FDA Preferred Term for this commodity. Detorubicin bears US NLM identifiers UMLS ID C0057578 and NCI Concept Code C1066. SMILES: O(C1CC(O)(CC2C1C(O)C1C(C2O)C(=O)C2C(C1=O)C(OC)CCC2)C(=O)COC(=O)C(OCC)OCC)C1OC(C(O)C(N)C1)C.

